News Conference News AHA 2015 Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding Todd Neale November 10, 2015
News Conference News AHA 2015 IVUS Tops Angiography for Guiding DES Implantation in Long Lesions Todd Neale November 09, 2015
News Conference News AHA 2015 DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year Yael L. Maxwell November 09, 2015
News Conference News AHA 2015 RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life L.A. McKeown November 09, 2015
News Conference News AHA 2015 Leadless Transcatheter Pacing Looks Good in the Short-term, But Long-term Questions Remain Yael L. Maxwell November 09, 2015
News Conference News AHA 2015 Female Cardiologists Underpaid and Outnumbered, with Ramifications for Patients and Profession Shelley Wood November 09, 2015
News Conference News AHA 2015 SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients Todd Neale November 08, 2015
News Conference News AHA 2015 Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain Shelley Wood November 08, 2015
News Conference News AHA 2015 CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure Shelley Wood November 08, 2015
News Conference News AHA 2015 AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More Shelley Wood November 05, 2015
News Conference News AHA 2014 Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts November 18, 2014
News Conference News AHA 2014 AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI Yael L. Maxwell November 18, 2014
News Conference News AHA 2014 Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel Yael L. Maxwell November 17, 2014
News Conference News AHA 2014 Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year Yael L. Maxwell November 17, 2014
Presentation AHA 2014 Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent Presenter: Dean J. Kereiakes November 16, 2014
Presentation AHA 2014 Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial Presenter: C.Kaiser November 16, 2014
News Conference News AHA 2014 Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 Long-Term Better than Short-Term Prasugrel After PES Stenting November 15, 2014